Failed SimbaM1 Deal May Weigh on Keppel Intensify Cost Pressures Across Singapore Telco Sector XBP Global XBP Q1 2026 Results Fall Short EPS 228 Revenue NA Cue Biopharma CUE Q3 2025 Earnings 210 EPS Surges Past 283 Estimates Klaviyo KVYO Crushes Q1 2026 Estimates EPS 022 Tops Views CUE Cue Biopharma beats Q3 estimates with 196 revenue surge but shares drop 2